From a comparison of the data sets obtained with MCF-7 versus MCF-7:5C cells treated with or without E2, and from a computationally-derived global AIB1-interacting network prediction, we identified pathways that participate in the differential response to E2 in these breast cancer cells. The gene discussed is NCOA3; the disease is breast cancer.